Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03438292 · ClinicalTrials.gov registry record · NA
The Absorption of Bioactive Berberine in Human
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03438292 is a NA study that has completed, run by University of Florida. The registered enrollment target is 32 participants.
The verdict
NCT03438292, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Berberine from medicinal plants has therapeutic activities against multiple chronic diseases. But its absorption rate is very low. The objective of this study is to test if adding TPGS or Quillaja extract as an emulsifier enhance the absorption of berberine in human.
Interventions
- DIETARY_SUPPLEMENT Berberine
- DIETARY_SUPPLEMENT TPGS emulsified berberine
- DIETARY_SUPPLEMENT Quillaja extract emulsified berberine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-09-25 |
| Est. Completion | 2020-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03438292
The ClinicalTrials.gov registry entry for NCT03438292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Berberine is the first listed.
NCT03438292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03438292 about?
NCT03438292 is a clinical study titled "The Absorption of Bioactive Berberine in Human". Berberine from medicinal plants has therapeutic activities against multiple chronic diseases. But its absorption rate is very low. The objective of this study is to test if adding TPGS or Quillaja extract as an emulsifier enhance the absorption of berberine in human.
What is the current status of trial NCT03438292?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-09-25. Estimated completion is 2020-09-11.
What interventions are being tested in trial NCT03438292?
The interventions under investigation include: Berberine (DIETARY_SUPPLEMENT), TPGS emulsified berberine (DIETARY_SUPPLEMENT), Quillaja extract emulsified berberine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03438292?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.